Develops cell and gene therapies for solid tumors and genetic diseases using proprietary platforms to create innovative medical treatments.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
CureGenetics is a clinical-stage biotechnology company specializing in developing cell and gene therapies for solid tumors and genetic diseases. Its proprietary platforms, AIMS CAR-NKT and VELP™ AAV, drive a diverse and differentiated pipeline. Through global collaborations and licensing agreements, Cure Genetics actively advances research, development, and commercialization of innovative therapies to address unmet medical needs worldwide.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
CureGenetics Management Team
CureGenetics Valuations & Financials
View real-time NPM data on CureGenetics stock including daily CureGenetics stock price estimates, valuation history, and historical share price information. Access CureGenetics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track CureGenetics pricing across six independent market signals. Looking for private company due diligence data sources on CureGenetics? Get in touch to learn more.
Similar Companies
like CureGenetics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Collectable
Web3 & Digital Assets
Provides a platform that lets users buy, sell, and trade fractional equity in rare and high‑value collectible assets.
Golden Plains Wind Farm
Large-scale wind farm development with integrated energy storage system to generate renewable power and enhance electrical grid stability.
Kopari Beauty
Consumer
Creates coconut-based skincare designed to nourish, hydrate, and simplify everyday routines.
CubicPV
Produces advanced silicon and perovskite wafers for high-efficiency tandem solar modules, lowering costs and carbon in clean energy.
Fianu Labs
Enterprise Software
Automates evidence capture and compliance enforcement in software delivery pipelines.
Tofu
Creates hyper-personalized, on-brand B2B marketing content at scale using AI and recommends tactics to boost campaign conversions.
Luminopia
Healthcare & Life Sciences
Use immersive digital content to improve visual function through engaging, brain-based treatment approaches.
Blueqat
Provides quantum computing cloud services and SDK solutions, offering access to advanced computational resources and development tools.
FAQ
We have answers
CureGenetics stock does not trade on public stock exchanges. CureGenetics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in CureGenetics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
CureGenetics Stock does not trade on public stock exchanges. In order to sell CureGenetics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
CureGenetics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view CureGenetics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for CureGenetics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell CureGenetics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in CureGenetics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
CureGenetics is a private company and has not had an IPO. There is currently no CureGenetics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to CureGenetics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
